Studies in rodents and more recently in humans immunized with RTS,S a leading malaria vaccine based on the CS protein [9], or irradiated sporozoites have shown that anti-CS antibodies are higher in protected individuals than in those non-protected [7], [10]. This evidence concerns the gene CS and malaria.